- Home
- RNXT vs MGN Comparison
RNXT vs MGN Comparison
Compare RNXT & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNXT | MGN |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 33.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNXT | MGN |
|---|---|---|
| Price | $0.92 | $0.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 456.3K | ★ 7.3M |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $267.59 | N/A |
| Revenue Next Year | $307.07 | N/A |
| P/E Ratio | ★ N/A | $32.33 |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.13 |
| 52 Week High | $1.45 | $5.18 |
Technical Indicators
Market Signals| Indicator | RNXT | MGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 31.96 |
| Support Level | $0.79 | $0.13 |
| Resistance Level | $1.07 | $2.25 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | -0.01 | -0.37 |
| Stochastic Oscillator | 7.53 | 3.34 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.